Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
NCT01795768
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Oesophageal Cancer
Breast Cancer
Squamous Cell Carcinoma of the Lung
Interventions
DRUG:
AZD 4547
Sponsor
Royal Marsden NHS Foundation Trust
Collaborators
[object Object]